Acetylcholine is an important regulator of local cerebral blood flow. There is, however, limited information available on the possible sites of action of this neurotransmitter on brain intraparenchymal microvessels. In this study, a com bination of molecular and functional approaches was used to identify which of the five muscarinic acetylcholine receptors (mAChR) are present in human brain microvessels and their intimately associated astroglial cells. Microvessel and capillary fractions isolate<;i from human cerebral cortex were found by reverse transcriptase-polymerase chain reaction to express m2, m3, and, occasionally, ml and m5 receptor subtypes. To local ize these receptors to a specific cellular compartment of the vessel wall, cultures of human brain microvascular endothelial and smooth muscle cells were used, together with cultured human brain astrocytes. Endothelial cells invariably expressed m2 and m5 receptors, and occasionally the ml receptor; smooth muscle cells exhibited messages for all except the m4 mAChR subtypes, whereas messages for all five muscarinic receptors Acetylcholine (ACh) is an important regulator of CBF in man and in many other species (for review see Sato and Sato, 1995; Dauphin and MacKenzie, 1995) . Intra cortical and basalocortical cholinergic nerve fibers have been shown to intimately associate with microarterioles and capillaries in the rat (Vaucher and Hamel, 1995) and 794 were identified in astrocytes. In all three cell types studied, acetylcholine induced a pirenzepine-sensitive increase (62% to 176%, P < 0.05 to 0.01) in inositol trisphosphate, suggesting functional coupling of ml, m3, or m5 mAChR to a phospho lipase C signaling cascade. Similarly, coupling of m2 or m4 mAChR to adenylate cyclase inhibition in endothelial cells and astrocytes, but not in smooth muscle cells, was demonstrated by the ability of carbachol to significantly reduce (44% to 50%, P < 0.05 to 0.0 I) the forskolin-stimulated increase in cAMP levels. This effect was reversed by the mAChR antagonist AF DX 384. The results indicate that microvessels are able to respond to neurally released acetylcholine and that mAChR, distributed in different vascular and astroglial compartments, could regulate cortical perfusion and, possibly, blood-brain barrier permeability, functions that could become jeopardized in neurodegenerative disorders such as Alzheimer's disease.
human (Tong and Hamel, 1997) cerebral cortex. Inter estingly, cholinergic-mediated increases in local CBF have been observed in the frontal and parietal subdivi sions of the cerebral cortex on stimulation of basal fore brain cholinergic neurons and muscarinic ACh receptors (mAChR), some of which, presumably associated with the local microcirculation, have been implicated in this response (for review see Sato and Sato, 1995) . Cerebro microvascular mAChR binding sites have indeed been reported (Estrada et aI., 1983) , and more recently, mul tiple mAChR subtypes have been identified in intracor tical microvessels and capillaries, including in man (Gar cia-Villal6n et aI., 1991; Linville and Hamel, 1995) . However, the absence of highly selective sUbtype specific ligands for all mAChR made it difficult to con clusively identify the exact receptor SUbtype involved. Furthermore, these radioligand binding studies in tissue homogenates could not localize mAChR to a specific cellular compartment of the isolated microvascular frac tions (Linville and Hamel, 1995; Moro et aI., 1995) .
In this respect, in addition to direct interactions with microvascular smooth muscle (SMC) and endothelial (EC) cells, ACh could also affect local brain perfusion and other microvascular functions through perivascular astrocytes (AST), suggested as intermediaries in the neu rogenic control of the microcirculation by cholinergic mechanisms (Vaucher and Hamel, 1995) . Interestingly, astrocytic processes associated with bovine and rat brain capillaries have been shown to express mAChR (Moro et aI., 1995; Luiten et aI., 1996) and could thus be involved in the local regulation of cortical perfusion through the release of vasoactive mediators (Alkayed et aI., 1997) .
Acetylcholine exerts its effects through any one of the five cloned mAChR subtypes, with downstream effects of either inositol phosphate activation (ml, m3, and m5) or attenuation of adenylate cyclase activity (m2 and m4) (for review see Felder, 1995) . In large cerebral arteries, activation of mAChR can result in different vascular re sponses depending on which mAChR subtype is stimu lated. Pharmacologic studies have identified the M3 mAChR subtype as the mediator of the ACh-induced endothelium-dependent dilation (Dauphin and Hamel, 1990; Garcia-Villalon et aI., 1991) , whereas the Ml sub type has been implicated in cerebral vasoconstriction (Dauphin et aI., 199 1; Shimizu et aI., 1993) . At the level of the brain microcirculation, ACh induces vasodilation of intracortical arterioles in rat (Dacey and Bassett, 1987) , bovine, and human (Elhusseiny and Hamel, 1998) . However, the subtypes and location of the recep tors involved in this and other putative ACh-mediated responses are not known.
In the present study, we used reverse transcriptase polymerase chain reaction (RT-PCR) to identify the mAChR expressed in human brain microvessels (MV) and capillaries (CAP). To examine the localization and operational behavior of the mAChR within the vessel wall, we evaluated receptor mRNA expression in cul tures of human brain microvascular (i.e., EC and SMC) and astroglial cells, and assayed their ability to couple to their expected second-messenger signaling pathways in cultured cells. The results show that human intracortical MV and CAP are endowed with multiple functional mAChR subtypes that exhibit a distinct cellular localiza tion within the vessel wall. These receptors could medi ate vasomotor responses in intracortical MV, either di rectly by activating receptors on SMC, or indirectly via receptors expressed on EC or perivascular AST.
MATERIALS AND METHODS

Isolated MV and CAP
Human brains (n = 6; average postmortem delay, 16.2 ± 2.2 hours; 4 men, 2 women) were obtained at autopsy from subjects who died from diseases not affecting the CNS, with approval from the Institutional Research Ethics Committee, either from the Brain Bank of the Douglas Hospital Research Centre (Ver dun, Quebec, Canada) or the department of pathology at the Royal Victoria Hospital (Montreal, Quebec, Canada). Intracor tical MV and CAP were isolated as described previously (Lin ville and Hamel, 1995) . Briefly, after homogenization and cen trifugation over 15% dextran, MV and CAP were harvested by filtration through a 151-[Lm and subsequently a 53-[Lm nylon mesh screen, respectively. Previous light microscopic exami nation of similarly prepared MV and CAP fractions have indi cated their high level of purity, as also shown by the enrichment (>30-fold) in the endothelial marker enzymes 'Y-glutamyl trans peptidase ('Y-GTP) and alkaline phosphatase over cerebral tis sue (see Linville and Hamel, 1995) .
Cell cultures
Cultures of human brain EC and SMC were produced, with approval from the Institutional Research Ethics Committee, from intracortical CAP and MV harvested from biopsies ob tained from patients (n = 6) undergoing surgery for the treat ment of temporal lobe epilepsy (Stanimirovic et aI., 1996; Abounader et aI., 1999) . In short, SMC cultures were generated from cortical homogenates that were sequentially filtered through a 350-[Lm and lI2-[Lm mesh. The resistance MV were then dislodged from these meshes with cold cell culture me dium M199 and dissociated with type IV collagenase (I mg/ mL; 15 minutes). After 4 to 5 weeks in culture, more than 85% of cells stained positively for the SMC marker (X-actin, whereas about 10% of cells demonstrated EC morphology and incorpo rated acetylated low-density lipoproteins (Abounader et aI., 1999) . Six primary cultures of SMC from different biopsies were used in this study.
Human microvascular and capillary EC cultures were grown from CAP obtained after the 112-[Lm filtrate had been further resuspended in M 199 medium and sieved through a 20-[Lm mesh screen. Endothelial cell colonies were isolated with clon ing rings and grown to confluence. More than 95% of cells in these cultures were immunopositive for factor VIII-related an tigen, incorporated acetylated low-density lipoproteins, and ex pressed high levels of cerebral endothelium-specific enzymes, 'Y-glutamyl-transpeptidase and alkaline phosphatase. Morpho logic, phenotypic, biochemical, and functional characteristics of these EC cultures have been described earlier (Stanimirovic et aI., 1996) . Both primary and passaged (3 to 7 times, n = 6) EC cultures were used in this study.
Cultures of fetal (10 to 18 weeks of gestation) human brain AST (n = 5) were provided by Drs. J. Antel and W. Yong (Montreal Neurological Institute, Montreal, QC, Canada) and prepared according to well-established procedures (for details, see Abounader et aI., 1999) . Brains were trypsinized (0.25%), homogenized, and filtered through a 130-fLm mesh. Cell pellets were resuspended in a 95% Dulbecco's modified Eagle's me dium containing 5% fetal bovine serum, and plated onto poly L-lysine-coated tissue culture dishes. Contaminating neurons were eliminated by trypsinization and passaging (2 to 5 times).
More than 95% of the cells in these cultures were immunoposi tive for the glial fibrillary acidic protein.
Reverse transciption-polymerase chain reaction
RNA isolation and reverse transcription. Primers. Specific primers were designed according to pub lished sequences of the cloned human mAChR genes for ml, m2 (Peralta et al., 1987) m3, m4 (Bonner et al., 1987) , and m5 (Bonner et aI., 1988) for 24 hours in serum-and inositol-free medium M199, as previously described (Stanimirovic et aI., 1996) . The cells were washed and exposed to ACh (I mmollL) alone or after a 15minute preincubation with the MI-preferring mAChR antago et al., 1991) , which was shown in preliminary experiments to have no significant effect (104% ± 24% of basal levels) on phosphoinositide production.
In some cases, the mAChR agonist carbachol (200 fLmollL) was also used. The stimulation was performed in the presence of 10 mmollL LiCI (Berridge et aI., 1982) 
RESULTS
Expression of mAChR in isolated microvascular fractions and cells in culture
The primers were found to be highly selective and to yield PCR products of the expected size exclusively when the amplification was performed on the Sf-9 cells infected with the corresponding cloned human mAChR (Fig. 1) . In all experiments, amplification of PCR prod- ucts for the various mAChR was not a result of genomic DNA contamination because they were exclusively de tected in samples that had been reverse transcribed (+RT lanes in Figs. 1, 2 , and 3, see also legends to these fig  ures) . Multiple types of mAChR were detected in MV and CAP isolated from human cerebral cortex (Fig. 2) . In MV, message for m3 mAChR was detected in a majority of preparations, whereas message for m 1 mAChR was seen only occasionally. In CAP, mRNA for m2 and m3 mAChR subtypes were consistently amplified, and PCR products corresponding in size to the ml and mS recep tors were also present, albeit in fewer preparations. Ex pression of the m4 mAChR was not detected in either of the isolated microvascular fractions (Table I) .
When studied in microvascular and astroglial cell cul tures, PCR products for the m2 and mS mAChR were invariably amplified in EC (Fig. 3) , and message for the m I receptor subtype was detected in some preparations (Table 1 ). In contrast, mRNA for the m3 mAChR sub type was not detected in any EC cultures, including the primary EC culture. In primary cultures of microvascular SMC, strong PCR signals could be demonstrated by gel analysis, only receptors that appeared in 50% or more of samples were considered to be conclusively present in the tissues. AST, astraglial cells; CAP, capillaries; EC, endothelial cells; MV, microvessels; SMC, smooth muscle cells. electrophoresis for the ml, m2, m3, and m5 mAChR, but not for the m4 subtype ( Fig. 3 and Table 1 ). In cultures of fetal human brain AST, expression of the five cloned human mAChR was evidenced by their expression level being generally very strong, as evaluated by gel electro phoresis ( Fig. 3 and Table 1 ). Sequence analysis of the selected PCR products showed that they unambiguously corresponded to the cloned human mAChR with the fol lowing accuracy: ml (99%), m2 (98%), m3 (99%), m4 (98%), and m5 (99%). This slight variation in sequence is fully acceptable for single-strand sequence analysis.
Second messenger assays IP3 assay. Addition of ACh (l mmoVL) to EC, SMC, and AST cell cultures resulted in a significant increase in IP3 production. The increase over basal levels was com parable in EC (62.6% ± 10.8%; P < 0.01) and SMC (63.5% ± 18.0%; P < 0.05), and somewhat higher in AST (176.2% ± 19.5%; P < 0.01) ( Fig. 4) . A similar increase (120% ± 34.3%) was obtained with 200 J..l mollL carba chol when tested in AST (not shown). In all three cell types, the ACh-induced IP3 production was significantly (P < 0.05) inhibited to near basal levels by preincubation with the mAChR antagonist pirenzepine (1 mmol/L) (Fig. 4) .
cAMP assay. Forskolin (1 J..l mollL) resulted in an 8-to 18-fold increase (P < 0.01) in cAMP levels in EC, SMC, and AST in culture. The cholinergic agonist carbachol (200 J..l mollL) significantly reduced the forskolin stimulated cAMP levels by 50% ± 23.4% (P < 0.05) in EC and 44% ± 10.2% (P < 0.01) in AST. Addition of the mAChR antagonist AF-DX 384 (10-5 mollL) signifi cantly antagonized the inhibitory effect of carbachol in both cell types, returning cAMP levels to 82.6% ± 7.1 % (P < 0.05) and 98.6% ± 11.4% (P < 0.01) of forskolin stimulated cAMP levels, respectively. In contrast, carba chol and AF-DX 384 had no significant effect on the forskolin-mediated increase in cAMP levels in SMC cul tures (n = 3) ( Fig. 5B) .
DISCUSSION
This study demonstrates that heterogeneous mAChR subtypes are localized in specific cellular compartments of the human brain microcirculation. Together MV and CAP isolated from postmortem human cerebral cortex were found to express a combination of mAChR, but to lack the m4 sUbtype. When receptor expression was as sessed in more details in microvascular and astroglial cell cultures generated from surgery specimens or fetal brains, the results indicated that human brain EC are endowed with m2 and m5 mAChR subtypes, SMC with ml, m3, and possibly m5 mAChR, whereas all five mAChR were found in human fetal brain AST. The re sults with mAChR antagonists further indicated that their second messenger coupling efficacy corresponded to that reported previously in EC and SMC cultures from pe- ripheral blood vessels of man (Hawley et aI., 1995) , or in rat glial cell cultures (Cohen and Almazan, 1994) . Alto gether, the present results suggest that intracortical MV have the ability to respond to changes in central cholin ergic neurotransmission either directly through receptors in the vessel wall itself or indirectly by interacting with receptors located on the perivascular astroglial cells. The presence of specific binding sites for the mAChR antagonist eH]quinuclidinylbenzilate in collagenase treated CAP and MV (Estrada et aI., 1983) provided the first convincing evidence that mAChR are associated with vascular elements of the brain microcirculation. Al though more than one population of mAChR were later suggested (Garda-Villalon et al., 199 1; Linville and Hamel, 1995) , there was disagreement as to which mAChR SUbtypes were present in the brain microvascu lature. Garda-Villalon and colleagues exclusively iden tified a pharmacologic m4 mAChR in bovine microvas cular fractions, but others concluded on the basis of phar macologic characterization and correlation analyses with the cloned mAChR that the ml, m3, and possibly the m5 receptors were most likely the cerebromicrovascular re ceptors present, not only in bovine, but also in human cerebromicrovascular fractions (Linville and Hamel, 1995) . In the present study, the high sensitivity and se lectivity of the RT-PCR approach, together with the demonstration of functional second messenger signaling pathways in the cell cultures, provided unequivocal sup port for the presence of cerebromicrovascular m 1, m3, and m5 mAChR, and further allowed us to identify en dothelial m2 mAChR. In contrast, m4 mAChR were found to be exclusively astroglial, a finding that could possibly explain its detection by radioligand binding studies in isolated bovine microvessels (Garcfa-Villalon et al., 1991) , as these also contain a proportion of at tached astroglial cells (for details, see Linville and Hamel, 1995) . Most interestingly, the present findings in the human intracortical microvascular bed closely match those reported in a recent RT-PCR study, which showed expression of ml, m2, m3, and m5 mAChR in the rat basilar artery (Phillips et al., 1997) . This remarkable similarity in the composition of mAChR between the rat major cerebral arteries and the human intracortical mi crovessels strongly suggests a high level of conservation for vascular mAChR across species and between intra parenchymal and extraparenchymal blood vessels. It may further imply comparable functions for these receptors in their respective cerebrovascular beds.
The RT-PCR results obtained in the EC cultures showed the presence of mAChR in these cells with a consistent and predominant expression of the m2 and m5 mAChR, a finding that was corroborated by their cou pling to the expected downstream signaling pathways but which is at variance with previous studies that could not detect mAChR in brain capillaries, albeit in the rat (Moro et al., 1995; Luiten et aI., 1996; Badaut et al., 1997) . However, the immunocytochemical demonstration of en dothelial m2 mAChR in rat, primate, and human brain capillaries Smiley et al., 1998) would argue to the contrary and rather support the present find ings. The exclusive mRNA expression of the m2 subtype and the ability of the mAChR antagonist AF-DX 384 (Dorje et aI., 199 1) to block the inhibitory effect of car bachol on cAMP production (the downstream effect of m2 activation) unequivocally indicated the existence of functional endothelial m2 mAChR. The apparent dis-crepancy between the present results and the inability of previous radioligand binding studies to detect m2 mAChR in isolated human cerebral microvasculature (Linville and Hamel, 1995) could possibly be explained by the fact that radioligand binding studies, unlike PCR, require that a sizable amount of the receptor protein be present to be detectable. In fact, from the present results, m2 receptors are located in the endothelial but not in the muscular compartment (see below) of the intraparenchy mal vascular tissue. It is thus possible that m2 binding sites in a single layer of EC would have been masked by more abundant mAChR subtypes present in both the EC and SMC, or the smooth muscle layers alone. This pu tative problem of relative abundance between the differ ent mAChR subtypes has been circumvented in the present study by the use of the highly sensitive PCR technique and cell cultures of the different cellular com ponents of the vessels wall.
With regard to mAChR associated with the phosphoi nositide pathway, the findings that only the m5 SUbtype was consistently expressed in human brain EC and that pirenzepine, which at the concentration used will affect not only ml but also the other mAChR subtypes (Dorje et aI., 199 1) , effectively inhibited the IP3 response in duced by ACh in these cultures further indicated the presence of entiothelial m5 mAChR proteins. No mo lecular evidence, however, was found in primary and passaged human cerebromicrovascular EC cultures for the m3 mAChR SUbtype. This finding suggests that its mRNA detection in isolated CAP is probably owing to other cells intimately associated with this isolated micro vascular fraction, such as pericytes or AST (see below), rather than to repeated passaging of the cells (Tracey and Peach, 1992) . In large cerebral arteries of various spe cies, the m3 mAChR (Dauphin and Hamel, 1990 ; Gar cia-Villalon et aI., 199 1; for review see Dauphin and Mackenzie, 1995) and the m5 SUbtype (Hamel et aI., 1994; Phillips et aI., 1997) have been suggested as pos sible mediators of the endothelium-dependent, nitric ox ide-mediated dilation induced by ACh. Because ACh is also a potent dilator of isolated intracortical arterioles in rat (Dacey and Bassett, 1987) , cow, and human, in which nitric oxide-mediated mechanisms appear to be involved (Elhusseiny and Hamel, 1998) , the present results sug gest that the m5 mAChR is a likely candidate for medi ating this response at the microvascular level in man. This receptor is known to share substantial similarities with the m3 mAChR subtype, both in terms of pharma cology (Dorje et aI., 199 1) and second messenger profile (Felder, 1995) . Furthermore, the m5 receptor has been reported to stimulate nitric oxide production when trans fected in cells (Wang et aI., 1994) , a property that could be of interest for a receptor putatively involved in an endothelium-dependent vasodilatory response. Addi tional studies with m5 mAChR-selective compounds will J Cereb Blood Flow Metab, Vol. 19, No.7. 1999 be of great help in clarifying this issue when they be come available.
Isolated MV, which unlike CAP are enriched with vessels with a smooth muscle layer, were found to ex press ml and m3 mAChR subtypes, a finding corrobo rated by the expression of these same receptors in mi crovascular SMC cultures. Although a role for these re ceptors in human brain microcirculation still has to be defined, both SUbtypes have been implicated in the ACh induced vasoconstriction of endothelium-denuded ves sels, with the ml subtype being particularly important at the level of cerebral blood vessels (for review see Dau phin and Mackenzie, 1995) . In spite of the detection of mRNA for the m2 receptor in SMC, carbachol system atically failed to significantly block the forskolin induced cAMP production in these cells, although it was very effective in EC and AST cultures. This observation suggests that the m2 mRNA is either amplified from the small population of contaminating EC present in the pri mary SMC cultures, or that functional m2 mAChR exist in a very limited population in SMC, too small to pro duce a significant effect on the cAMP production in a biochemical assay. The presence of m5 mAChR in both EC and SMC cultures similarly indicate that further in vestigations will be needed to verify whether the m5 mAChR is genuinely expressed in SMC or whether its detection in these cells is because of the small proportion of contaminating EC. However, as for other microvas cular receptors (Riad et aI., 1998) , it is also possible that the same receptor SUbtype is expressed in both the EC and SMC compartments.
Our finding that human brain AST express all five mAChR extends previous pharmacologic and molecular studies that showed the presence of m2, m3, and m5 mRNA in human astrocytoma cells (Guizzetti et ai., 1996) , and ml and m3 in murine astroglial cells in cul ture (Andre et aI., 1994) . In addition to the ml, m2, m3, and m5 subtypes, we further show expression of the m4 mAChR in fetal human brain AST. Its presence in adult human brain AST should be further confirmed, as fetal brain tissue and AST may express different receptor populations than those seen in the adult (Van der Zee et aI., 1993; Hohmann et aI., 1995), a possibility raised by the absence of m4 mAChR message in either isolated MV or CAP that originated form adult brain. Astroglial cells fulfill a variety of functions within the central ner vous system (Van der Zee et ai., 1993; Guizzetti et ai., 1996) and the multiplicity of mAChR associated with these cells could be a reflection of such a polyvalence. More specifically, perivascular astroglial cells have been involved in the regulation of microvascular tone, meta bolic homeostasis, and blood-brain barrier permeability (Tao-Cheng et aI., 1987; Tsacopoulos and Magistretti, 1996; Alkayed et aI., 1997) , all of which could be regu lated by ACh because a large proportion of neurovascu-lar cholinergic nerve terminals are in fact associated with the perivascular AST (Vaucher and Hamel, 1995) .
PHYSIOLOGIC IMPLICATIONS
This study reports the presence of functional cerebro microvascular and astroglial mAChR in human cerebral cortex, corresponding in part to those able to mediate vasomotor responses in other cerebrovascular beds (for review see Dauphin and MacKenzie, 1995) . Cortical MV and CAP have been identified as a target for basalocor tical cholinergic nerve terminals in both rat (Vaucher and Hamel, 1995) and human (Tong and Hamel, 1997) . The present results further indicate that these intraparenchy mal vessels are equipped with adequate receptors to di rectly modulate blood flow in response to cholinergic stimulation, in agreement with many physiologic studies involving stimulation of basal forebrain neurons (for re view see Sato and Sato, 1995) . Furthermore, dysfunc tions in this system, like those seen during neurodegen erative disorders such as Alzheimer's disease, could impact on the regulation of the local cortical microcir culation and result in inadequate perfusion, capillary morphology, or blood-brain barrier permeability.
